DBV Technologies | DBVT - Actif À Court Terme





Actif À Court Terme Changement Date
Acadia Pharmaceuticals USD 1.22B 128.53M 2026-06
Alnylam Pharmaceuticals USD 4.62B 400.86M 2026-06
Amarin USD 602.76M 23.26M 2026-06
BioCryst Pharmaceuticals USD 484.68M 111.06M 2026-06
BioMarin Pharmaceutical USD 3.97B 633.45M 2026-06
DBV Technologies USD 201.9M 44.8M 2026-06
Galectin Therapeutics USD 27.29M 1.83M 2024-06
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
Incyte USD 6.03B 542.31M 2026-06
Insmed USD 1.63B 20.75M 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Neurocrine Biosciences USD 1.64B 798.6M 2026-06
PTC Therapeutics USD 2.62B 363.36M 2026-06
Sarepta Therapeutics USD 2.22B 86.05M 2026-06
Ultragenyx Pharmaceutical USD 606M 51M 2026-06
United Therapeutics USD 3.48B 611.7M 2026-06